Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study

Ahlqvist, 2018, Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables, Lancet Diabetes Endocrinol, 6, 361, 10.1016/S2213-8587(18)30051-2 2018, 2: classification and diagnosis of diabetes—standards of medical care in diabetes, 2018, Diabetes Care, 41, S13 Wallace, 2004, Use and abuse of HOMA modeling, Diabetes Care, 27, 1487, 10.2337/diacare.27.6.1487 Stidsen, 2018, Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool, Diabetes Metab Res Rev, 34, 10.1002/dmrr.3005 Prasad, 2019, Precision medicine in type 2 diabetes, J Intern Med, 285, 40, 10.1111/joim.12859 Callaghan, 2012, Diabetic neuropathy: clinical manifestations and current treatments, Lancet Neurol, 11, 521, 10.1016/S1474-4422(12)70065-0 Bönhof, 2019, Emerging biomarkers, tools, and treatments for diabetic polyneuropathy, Endocr Rev, 40, 153, 10.1210/er.2018-00107 2016, EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease, J Hepatol, 64, 1388, 10.1016/j.jhep.2015.11.004 Tilg, 2017, NAFLD and diabetes mellitus, Nat Rev Gastroenterol Hepatol, 14, 32, 10.1038/nrgastro.2016.147 Dulai, 2017, Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis, Hepatology, 65, 1557, 10.1002/hep.29085 Szendroedi, 2016, Cohort profile: the German Diabetes Study (GDS), Cardiovasc Diabetol, 15, 59, 10.1186/s12933-016-0374-9 Zaharia, 2018, Metabolic characteristics of recently diagnosed adult-onset autoimmune diabetes mellitus, J Clin Endocrinol Metab, 103, 429, 10.1210/jc.2017-01706 Inker, 2012, Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med, 367, 20, 10.1056/NEJMoa1114248 Levey, 2003, National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Ann Intern Med, 139, 137, 10.7326/0003-4819-139-2-200307150-00013 Gastaldelli, 2017, Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study, Diabetes, 66, 815, 10.2337/db16-1167 Xiao, 2017, Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis, Hepatology, 66, 1486, 10.1002/hep.29302 Kahl, 2014, Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial, Diabetologia, 57, 2094, 10.1007/s00125-014-3328-3 Laufs, 2014, Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner, Magn Reson Med, 71, 1670, 10.1002/mrm.24835 Bonhof, 2017, Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy, Diabetologia, 60, 2495, 10.1007/s00125-017-4438-5 Young, 1993, A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population, Diabetologia, 36, 150, 10.1007/BF00400697 Dyck, 2011, Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity, Diabetes Metab Res Rev, 27, 620, 10.1002/dmrr.1226 Ziegler, 1992, Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy, Diabet Med, 9, 806, 10.1111/j.1464-5491.1992.tb01898.x Ziegler, 2018, Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes, Metabolism, 79, 1, 10.1016/j.metabol.2017.10.013 Solomon, 2017, Diabetic retinopathy: a position statement by the American Diabetes Association, Diabetes Care, 40, 412, 10.2337/dc16-2641 Samuel, 2012, Mechanisms for insulin resistance: common threads and missing links, Cell, 148, 852, 10.1016/j.cell.2012.02.017 Gancheva, 2018, Interorgan metabolic crosstalk in human insulin resistance, Physiol Rev, 98, 1371, 10.1152/physrev.00015.2017 2004, Dyslipidemia management in adults with diabetes, Diabetes Care, 27, s68 Biddinger, 2008, Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis, Cell Metab, 7, 125, 10.1016/j.cmet.2007.11.013 Koliaki, 2015, Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis, Cell Metab, 21, 739, 10.1016/j.cmet.2015.04.004 Kahl, 2014, Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance, PLoS One, 9, 10.1371/journal.pone.0094059 Spoto, 2016, Insulin resistance in chronic kidney disease: a systematic review, Am J Physiol Renal Physiol, 311, F1087, 10.1152/ajprenal.00340.2016 Pieralice, 2018, Latent autoimmune diabetes in adults: a review on clinical implications and management, Diabetes Metab J, 42, 451, 10.4093/dmj.2018.0190